Analyzing the causal relationship between lipid-lowering drug target genes and epilepsy: a Mendelian randomization study
BackgroundPrevious research has yielded conflicting results on the link between epilepsy risk and lipid-lowering medications. The aim of this study is to determine whether the risk of epilepsy outcomes is causally related to lipid-lowering medications predicted by genetics.MethodsWe used genetic ins...
Main Authors: | Shicun Huang, Yuan Liu, Yi Zhang, Yiqing Wang, Ya Gao, Runnan Li, Lidong Yu, Xiaowei Hu, Qi Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1331537/full |
Similar Items
-
Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study
by: Hao Qin, et al.
Published: (2023-07-01) -
Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study
by: Zilong Tan, et al.
Published: (2023-12-01) -
Causal relationship between circulating lipid traits and periodontitis: univariable and multivariable Mendelian randomization
by: Gaofu Hu, et al.
Published: (2023-07-01) -
Association between lipid-lowering drugs and allergic diseases: A Mendelian randomization study
by: Yinsong Xu, MM, et al.
Published: (2024-04-01) -
Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study
by: Wuqing Huang, et al.
Published: (2021-12-01)